Our first achievement is the construction of composite parts, which are composed of multiple basic parts to form plasmids that perform certain functions.
This year, we simultaneously utilized some of the basic elements, namely our previous designs, and also some new innovative designs to finish our project. Compared to the components that simply leads to an increase in the expression of insulin in previous years, we have added a braking system to the design in order to achieve more precise control of insulin concentration.
Fig 1. Composite parts
Our contribution is the construction of the above composite parts, which are composed of multiple basic parts
to form plasmids that perform certain functions. All of these may be helpful to other teams, and we hope it
will make contributions to the iGEM community.
(For detailed information, please visit the PARTS in our wiki.)
pcDNA3.1-LOV-VP16 is a specially designed expression vector, integrating the superior performance of pcDNA3.1 plasmid with the unique function of LOV-VP16 fusion protein. pcDNA3.1, a widely-used high-efficiency expression vector in mammalian cells, harbors a potent CMV promoter, driving high expression of foreign genes in various mammalian cell lines. The LOV domain, derived from a photosensitive protein, senses blue light signals and undergoes conformational changes; the VP16 domain significantly enhances gene transcription. When fused, the LOV-VP16 protein enables precise control of target gene expression under blue light regulation.
Fig 2. Structure of the LOV-VP16 plasmid
GIPpromoter-GI-GAL4 plasmid is a specialized vector integrating a specific promoter, reporter gene, and transcription factor. It employs the GIP (Glucose-dependent Insulinotropic Polypeptide) promoter, a DNA sequence with tissue specificity and regulatory properties, capable of initiating downstream gene expression in response to glucose concentration changes. In this plasmid, the GAL4 domain is linked to or regulated by the reporter gene, enabling it to drive reporter gene expression when GAL4 is activated, such as through binding to specific ligands or interacting with other transcription factors.
Fig 3. Structure of the GIPpromoter-GI-GAL4 plasmid
The GIPpromoter-LOV-VP16 plasmid integrates the LOV domain, allowing precise gene expression regulation via blue light. VP16, a powerful transcriptional activator, forms a LOV-VP16 fusion. Blue light triggers a conformational change in LOV, potentially activating VP16 and driving downstream gene expression.
Fig 4. Structure of the GIPpromoter-LOV-VP16 plasmid
In the GIPpromoter-sponge plasmid, the sponge sequence is designed to express a piece of RNA that specifically binds to a large number of specific microRNA molecules, thereby inhibiting miRNA activity. By integrating the sponge sequence into the plasmid, the level of specific RNAs within the cell can be regulated, which in turn affects the expression of related genes.
Fig 5. Structure of the GIPpromoter-sponge plasmid
The 5XUAS-insulin-miR-2BS plasmid is a specialized vector that combines specific enhancer sequences, the target gene, and microRNA binding sites. Here, the transcriptional activation efficiency was enhanced by tandemly linking 5 UAS sequences, making the expression of downstream genes more sensitive and efficient. Additionally, we have also integrated miR-2BS after the luciferase reporter gene, allowing miRNAs to bind to it and to regulate the expression of the luciferase reporter gene.
The 5XUAS-insulin-miR-2BS plasmid is a specialized vector that combines specific enhancer sequences, the target gene, and microRNA binding sites. Here, the transcriptional activation efficiency was enhanced by tandemly linking 5 UAS sequences, making the expression of downstream genes more sensitive and efficient. Additionally, we have also integrated miR-2BS after the luciferase reporter gene, allowing miRNAs to bind to it and to regulate the expression of the luciferase reporter gene.
Fig 6.Structure of the 5XUAS-LUC-miR-2BS plasmid
Our second contribution was to verify the functions of the plasmids we conducted through a series of
experimental tests.
For our AND circuit, we ensured that when the glucose concentration reached a certain threshold, that was, in
the presence of blue light irradiation, the GIP-driven expression of Gal4 and VP16 would bind to each other, and
would therefore trigger the up-regulation of insulin expression in the pGIP plasmid in the Gal4-VP16 system.
Fig 7. Blue light can stimulate the formation of an active transcription factor from GI-Gal4 and LOV-VP16
For the NOT circuit, since the expressed and bound GAL4-VP16 did not degrade but continuously promoted insulin synthesis, we specifically designed a 5XUAS-Luc-miRNA BS plasmid, and designed a miRNA system to inhibit the expression of insulin/luciferase. We utilized GIP promoter to link the coding sequences of sponge, which worked similarly to sponge adsorption of water. The sponge was able to specifically adsorb miRNAs and played the role of binding miRNA and disinhibiting the miRNA effect.
Fig 8. The disinhibition effect of sponge
(For detailed information, please visit the RESULTS in our wiki.)
Our third contribution was to successfully conduct our hardware. In order to regulate the production of the
Gal4-VP16 transcription factor, we employed blue light as a regulatory tool, ensuring that the system
could promote the appropriate synthesis and the release of insulin when needed by the body, while avoiding
excessive insulin production that could lead to hypoglycemia. Here, we have specifically designed the Blue
Light instrument as our hardware.
This year, we have improved on the previous 2021 hardware design, building on it in addition to our Blue Light
instrument. It consists of three parts: Glucose Detection Device, Monitor, and Instrument Emitting Blue Light.
When we soak both ends of the test strip into the solution to be measured and insert it into the test
instrument, the instrument measures the glucose concentration of the solution to be measured and puts this value
on the display first. At the same time, the blue light device will selectively emit blue light according to the
relationship between the value and the size of the threshold, which plays an obvious role in indication.
Fig 9.A photo of our Blue Light instrument
[1] Li CY, Wu T, Zhao XJ, Yu CP, Wang ZX, Zhou XF, Li SN, Li JD. A glucose-blue light
AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabetes in mice. Front Bioeng
Biotechnol. 2023 Feb 10;11:1052607.
[2] Alsunaidi B, Althobaiti M, Tamal M, Albaker W, Al-Naib I. A Review of Non-Invasive Optical Systems for
Continuous Blood Glucose Monitoring. Sensors (Basel). 2021 Oct 14;21(20):6820.
[3] Boylan MO, Jepeal LI, Jarboe LA, Wolfe MM. Cell-specific expression of the glucose-dependent
insulinotropic
polypeptide gene in a mouse neuroendocrine tumor cell line. J Biol Chem. 1997 Jul 11;272(28):17438-43.
[4] Sadowski I, Ma J, Triezenberg S, Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator.
Nature. 1988 Oct 6;335(6190):563-4.